Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Golden Minerals Co.

Start price
Target price
Perf. (%)
€6.35
10.01.23
-
10.01.24
-62.20%
11.01.24

buy
Ocuphire Pharma Inc.

Start price
Target price
Perf. (%)
€3.20
10.01.23
€6.00
31.12.25
-28.13%
26.01.23

Could be very worthwhile Investment >20% year
buy
Immunogen Inc.

Start price
Target price
Perf. (%)
€3.98
09.01.23
€8.00
31.12.25
178.89%
05.05.23

Could be very worthwhile Investment >20% year
buy
Nordex SE

Start price
Target price
Perf. (%)
€13.97
09.01.23
-
09.02.27
-12.82%
11.03.24

Could be worthwhile Investment >10% per year
buy
BayWa AG VNA

Start price
Target price
Perf. (%)
€42.80
09.01.23
-
09.02.27
-34.81%
11.03.24

Could be worthwhile Investment >10% per year
buy
Plug Power Inc.

Start price
Target price
Perf. (%)
€12.84
09.01.23
€20.00
09.01.24
15.30%
21.01.23

Good rating
Growths much faster than the competition
Leading role in innovation
Very good company culture
Bed Bath & Beyond Inc.

Start price
Target price
Perf. (%)
€1.76
09.01.23
-
09.01.24
74.24%
21.01.23

Capable Management
Good culture
Could be worthwhile Investment >10% per year
Little innovation
buy
Galaxy Digital Holdings Ltd.

Start price
Target price
Perf. (%)
€3.07
09.01.23
-
20.04.26
131.22%
12.01.24

Very high cyclical dependencies
Probably not worthwhile Investment
buy
Marathon Digital Holdings

Start price
Target price
Perf. (%)
€3.82
09.01.23
-
09.01.24
106.03%
17.01.23

Could be worthwhile Investment >10% per year
Very high cyclical dependencies
buy
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€43.10
09.01.23
-
09.01.24
-0.35%
21.01.23

Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth > 30% per year expected
buy
Drägerwerk AG & Co. KGaA ST

Start price
Target price
Perf. (%)
€38.00
09.01.23
-
09.01.24
-1.05%
21.01.23

Fair valuation
Top 10 in its market
Future proof or reliable business model
Could be worthwhile Investment >10% per year
buy
Marathon Digital Holdings

Start price
Target price
Perf. (%)
€3.86
08.01.23
-
08.01.24
100.00%
17.01.23

Risky Investment
buy
Photronics Inc.

Start price
Target price
Perf. (%)
€16.00
06.01.23
€19.50
06.01.24
-18.00%
28.04.23

buy
Kulicke & Soffa Industries Inc.

Start price
Target price
Perf. (%)
€42.29
06.01.23
€54.00
06.01.24
13.27%
25.05.23

Could be very worthwhile Investment >20% year
Undervalued
Capable Management
Significant cyclical dependencies
buy
AT&S Austria Technologie & Systemtechnik AG

Start price
Target price
Perf. (%)
€33.70
06.01.23
€40.00
06.01.24
0.30%
07.01.23

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
High Investments for future growth
buy
Cytomx Therapeutics Inc

Start price
Target price
Perf. (%)
€1.73
05.01.23
€3.00
31.12.25
37.80%
06.01.23

Could be very worthwhile Investment >20% year
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€6.46
04.01.23
€12.00
31.12.25
63.49%
05.05.23

Could be very worthwhile Investment >20% year
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€39.20
04.01.23
-
04.01.24
-60.00%
20.01.23

Could be worthwhile Investment >10% per year
buy
Marathon Digital Holdings

Start price
Target price
Perf. (%)
€3.68
04.01.23
€5.00
31.12.25
25.54%
09.01.23

Could be very worthwhile Investment >20% year
buy
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€24.80
04.01.23
-
04.01.24
-33.71%
22.01.23

Geron Corp.

Start price
Target price
Perf. (%)
€2.80
04.01.23
-
04.01.24
-29.37%
02.04.23

Risky Investment
buy
Geron Corp.

Start price
Target price
Perf. (%)
€2.50
04.01.23
€6.00
31.12.25
38.38%
04.01.23

Could be very worthwhile Investment >20% year
buy
Rigel Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€1.27
03.01.23
-
03.01.24
-5.60%
08.01.23

Could be worthwhile Investment >10% per year
Meta Material Inc.

Start price
Target price
Perf. (%)
€1.04
03.01.23
-
03.02.23
-6.57%
24.01.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.55
03.01.23
-
03.01.24
78.44%
14.05.23

Could be worthwhile Investment >10% per year